Literature DB >> 30346848

Total emitted dose of salbutamol sulphate at different inhalation flows and inhalation volumes through different types of dry powder inhalers.

Marian S Boshra1, Ahmed G Almeldien2, Randa Salah Eldin3, Ahmed A Elberry4, Nada Sayed Abdelwahab5, Mohamed Nabil Salem6, Hoda Rabea1, Mohamed E A Abdelrahim7.   

Abstract

The aim of the present study was to compare the performance of two different dry powder inhalers (DPIs) at different inhalations volumes and inhalation flows. Ventolin Diskus contain blisters of 200µg salbutamol. To test the TED from Aerolizer, salbutamol in Diskus blister was emptied and placed in size 3 capsules suitable for use with Aerolizer. Total emitted dose (TED) delivered by Diskus and Aerolizer was determined using DPI sampling apparatus after one and two inhalations from the same dose. 10-60L/min inhalation flows at 2 and 4L inhalation volume were used in the determination. At inhalation flow ≤30L/min, two inhalations resulted in higher TED than one inhalation (p < 0.05) and Diskus resulted in higher TED than Aerolizer (p < 0.05). The highest TED was at inhalation flow 40L/min above which the effect of the second inhalation and formula device relation were negligible. Device formula relation is present at low inhalation flow but at flow >30L/min Diskus drug formula can be delivered by Aerolizer with no significant difference in TED produced. For the best TED patients are required to inhale as fast as possible (a minimum of 40L/min). At lower inhalation flow two inhalations results in better emitted dose than one inhalation for both DPIs. So, we recommend patients with poor inspiratory efforts to inhale twice and as hard and deep as possible from each dose as they may not receive much benefit from one inhalation even when using DPI with low resistance (Aerolizer) or medium resistance (Diskus). However, further in-vivo study are required to validate this recommendtation.

Entities:  

Keywords:  DPIs; aerolizer; diskus; inhalation flow; total emitted dose

Mesh:

Substances:

Year:  2018        PMID: 30346848     DOI: 10.1080/01902148.2018.1489015

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  3 in total

Review 1.  Performance Characteristics of Breezhaler® and Aerolizer® in the Real-World Setting.

Authors:  Mathieu Molimard; Ioannis Kottakis; Juergen Jauernig; Sonja Lederhilger; Ivan Nikolaev
Journal:  Clin Drug Investig       Date:  2021-03-25       Impact factor: 2.859

2.  The effect of inspiratory parameters after two separate inhalations on the dose emission of theophylline from low and high resistance dry powder inhalers.

Authors:  Mohamad Abadelah; Jumannah Al-Assadi; James Rooney; Hassane Larhrib
Journal:  Saudi Pharm J       Date:  2019-11-13       Impact factor: 4.330

Review 3.  Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Jill A Ohar; Gary T Ferguson; Donald A Mahler; M Bradley Drummond; Rajiv Dhand; Roy A Pleasants; Antonio Anzueto; David M G Halpin; David B Price; Gail S Drescher; Haley M Hoy; John Haughney; Michael W Hess; Omar S Usmani
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.